Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03165916 · ClinicalTrials.gov registry record · NA
Study to Compare the Incidence of Biliary Complications After Liver Transplantation
A NA study of Liver Transplant, Complications, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 146
- Enrollment target
- 1
- Study location
NCT03165916: Completed NA study of Liver Transplant, Complications, sponsored by Vanderbilt University Medical Center.
NCT03165916 is a NA study of Liver Transplant, Complications that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 146 participants, below the 514-participant average among 7 other Liver Transplant, Complications trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03165916, a NA study of Liver Transplant, Complications, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 146 participants
- Enrollment target
- 1
- Study location
Study Summary
A randomized prospective study will be conducted of patients at Vanderbilt University Medical Center who undergo liver transplantation from March 2014 until approximately 120 patients are randomized. Patients will be randomized to undergo biliary reconstruction with and without stent placement.
Primary Outcome
Biliary complications include biliary strictures, biliary leaks, cholangitis, and stones. The investigators will compare the number of complications between the group that receives the stent and the group that does not.
Conditions Studied
Interventions
- DEVICE Bard 5 Fr diameter feeding tube
Study Locations (1)
Tennessee
- Vanderbilt Medical Center Liver Transplant Clinic - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2014-09-15 |
| Est. Completion | 2019-09-30 |
| Phase | NA |
What the finished NCT03165916 record still lists
NCT03165916 is an interventional study that assigns participants to a tested intervention. The registered 146 participants enrollment target is mid-sized for trials with a published cap, below the 514-participant average among 7 other Liver Transplant, Complications trials with a reported enrollment target (72% lower).
The record links to 1 condition, with Liver Transplant, Complications appearing as the primary indexed condition, and to 1 intervention - of which Bard 5 Fr diameter feeding tube is the first listed.
NCT03165916 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT03165916 about?
NCT03165916 is a clinical study titled "Study to Compare the Incidence of Biliary Complications After Liver Transplantation". A randomized prospective study will be conducted of patients at Vanderbilt University Medical Center who undergo liver transplantation from March 2014 until approximately 120 patients are randomized. Patients will be randomized to undergo biliary reconstruction with and without stent placement.
What is the current status of trial NCT03165916?
This trial is currently completed. It is a NA study. The enrollment target is 146 participants. The study started on 2014-09-15. Estimated completion is 2019-09-30.
What conditions does trial NCT03165916 study?
This clinical trial studies the following conditions: Liver Transplant, Complications.
What interventions are being tested in trial NCT03165916?
The interventions under investigation include: Bard 5 Fr diameter feeding tube (DEVICE).
Who is sponsoring clinical trial NCT03165916?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03165916 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Transplant, Complications
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
HEalth Advocate for Liver Transplant - Pilot
RECRUITING · NA
-
Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant
RECRUITING · NA
-
HEalth Advocate for Liver Transplantation: Improving Transition of Care for Adolescent Liver Transplant Recipients
RECRUITING · NA
-
Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation
RECRUITING · Phase 2
-
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
RECRUITING
-
Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03490929 · 146 participants · Phase 4
CEUS for Blunt Abdominal Trauma in Children
- NCT04755062 · 146 participants · NA
A Culturally-relevant Micronutrient-dense Plant-rich (mNDPR) Dietary Intervention for Native Americans
- NCT04867954 · 146 participants
Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis
- NCT05051618 · 146 participants · NA
Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI